Status
Conditions
About
To evaluate Non-Small Cell Lung Cancer (NSCLC) patients clinical profile and the outcome after treatment with Gefitinib in Pulmonary Oncology Outpatient Clinic Dr. Soetomo General Hospital, Surabaya, Indonesia.
Full description
Primary Objective: To determine the efficacy of Gefitinib in NSCLC patient harboring a positive EGFR mutation.
Secondary Objective: To evaluate the subjective response of NSCLC patients harboring a positive EGFR mutation who treated with Gefitinib.
Safety Objective: To evaluate the safety and tolerability of Gefitinib in NSCLC patient harboring a positive EGFR mutation.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Loading...
Central trial contact
Anna Febriani, MD; Laksmi Wulandari, MD, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal